Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFM 2005-01: Velcade-Dexamethasone vs VAD in Newly Diagnosed Multiple Myeloma
NCT00200681Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Jun 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by CHU de Nantes. Started Jun 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00200681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200681.